← Open Payments lookup

JOAN TADDEI: Open Payments

NPI 1760148381 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,791 in 130 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,693 · 2025 $2,791

Food & beverage: $2,791
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$328
Takeda Pharmaceuticals U.S.A., Inc.14$325
PFIZER INC.12$306
ABBVIE INC.18$280
Madrigal Pharmaceuticals13$249
Janssen Biotech, Inc.8$248
Ardelyx, Inc.10$206
QOL Medical, LLC10$162
Aimmune Therapeutics, Inc.4$110
GENZYME CORPORATION5$96

Products named: XIFAXAN, REZDIFFRA, TREMFYA, ENTYVIO, IBSRELA, RINVOQ, Sucraid, XELJANZ.

Industry payments across DE — which companies pay providers there.